SEBI may ease borrowing rules to give mutual funds more flexibility in managing cash

Govt begins search for 2 whole-time Sebi members; invites applications

The government has invited applications to fill two whole-time member posts at the markets regulator Securities and Exchange Board of India (Sebi). Currently, there are four whole-time members (WTMs), including Kamlesh Chandra Varshney, Amarjeet Singh, Sandip Pradhan and KVR Murty. Varshney and Singh will complete their three-year tenure in September, although they are eligible for…

Read More
John Cockerill India bags ₹440–470 crore order from JSW Steel Coated Products

John Cockerill India, subsidiary win order worth up to 1,300 cr from JSW Vijayanagar

Industrial engineering company John Cockerill India Ltd and its wholly-owned subsidiary John Cockerill Metal International SA have received a contract from JSW Vijayanagar Metallics for the design, engineering, supply, building supervision and commissioning of annealing and pickling lines for a CRNO project. The aggregate contract value is estimated at ₹1,250-1,300 crore. John Cockerill India on…

Read More
Oyo IPO soon? Parent Prism gets Sebi's nod to launch Rs 6,650-cr public issue - Details - Markets

Oyo IPO soon? Parent Prism gets Sebi’s nod to launch Rs 6,650-cr public issue – Details – Markets

Prism, the parent firm of global travel tech unicorn Oyo, has received the approval of the markets regulator Sebi to raise Rs 6,650 crore through its initial public offering (IPO), people familiar with the development said on Tuesday, as reported by news agency PTI. Earlier in December-end 2025, OYO’s parent entity PRISM filed the preliminary…

Read More
Concord Biotech gets FDA nod for immunosuppressant mycophenolate mofetil

Concord Biotech gets FDA nod for immunosuppressant mycophenolate mofetil

Pharmaceutical company Concord Biotech Ltd on Tuesday (June 2) said it has received approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for mycophenolate mofetil for oral suspension USP, 200 mg/mL. The company said mycophenolate mofetil is an antimetabolite immunosuppressant indicated for the prophylaxis of organ rejection in…

Read More
NHPC OFS: Issue subscribed 3.47 times on day 1, govt to exercise full 3% greenshoe option | Details - Markets

NHPC OFS: Issue subscribed 3.47 times on day 1, govt to exercise full 3% greenshoe option | Details – Markets

The government’s offer for sale (OFS) in NHPC was subscribed 3.47 times on June 2, DIPAM Secretary Arunish Chawla said. He added that allocation will be carried out on a price-priority basis. Retail investors and employees can place bids on June 3, 2026, while the government will exercise the entire 3 per cent greenshoe option…

Read More
Glove makers flag surge in substandard imports, seek urgent govt enforcement of quality norms

BofA sees domestic growth, Semaglutide opportunity driving pharma in FY27

India’s pharmaceutical sector enters FY27 on a strong footing, backed by improving domestic demand, new product opportunities and healthy balance sheets, according to Neha Manpuria, Senior Analyst – Pharma, Healthcare at BofA Global Research. The March quarter reflected broad-based strength across the industry, with domestic formulations emerging as a key growth driver. Market growth in…

Read More
Stock Market Today, June 2: Sensex ends 4-day losing streak, closes 382 higher; Nifty above 23450 - check gainers and losers | Closing Bell - Markets

Stock Market Today, June 2: Sensex ends 4-day losing streak, closes 382 higher; Nifty above 23450 – check gainers and losers | Closing Bell – Markets

Sarmeeli Mallick is a senior journalist with nearly a decade of experience in digital journalism. With a master’s degree in Journalism and Mass Communication from Utkal University, Bhubaneswar, she has a proven track record of impactful reporting, having filed over 19,000 news stories since beginning her career in May 2016. Her diverse background, rooted in…

Read More